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Inflammatory myofibroblastic tumor (IMT) is an uncommon mesenchymal solid tumor commonly documented in children 
and young adults. Here, we report a case of IMT in colon confirmed pathologically after laparoscopic anterior resection. A 
35-year-old man presented with anal bleeding after defecation for 2 weeks. Colonoscopy demonstrated a mass with shallow 
ulceration in the central area and irregular margin accompanied by intact mucosa in the descending colon. Computer tomog-
raphy showed a well-demarcated and homogenous solitary mass in the descending colon. We performed laparoscopic ante-
rior resection. This case was diagnosed as IMT after microscopic examination. The tumor was composed of a proliferation of 
spindle-shaped cells arranged in the hyaline material with chronic inflammatory cells, composed mainly of plasma cells and 
lymphocytes. Immunohistochemically, tumor cells were positive for smooth muscle actin, and vimentin, and negative for 
desmin, CD117 (c-kit), anaplastic lymphoma kinase-1.
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INTRODUCTION
Inflammatory myofibroblastic tumor (IMT) is an un-
common mesenchymal solid tumor commonly docu-
mented in children and young adults [1,2]. Although it oc-
curs primarily in the lung, IMTs in many organs including 
stomach, small intestine, large intestine, liver, mediasti-
num, retroperitoneum and bladder have also been docu-
mented [1,2]. The clinical presentation is determined by 
the site of origin and the effects of the mass. Thus, IMT 
presents with non-specific clinical symptoms and its diag-
nosis can be difficult. IMT derived from the gastrointesti-
nal (GI) tract presents with clinical symptoms of anemia, 
GI obstruction, fecal occult blood positive or intussus-
ception. Those are not specific symptoms in IMT because 
other GI tract tumor may also present with similar symp-
toms [1,3,4]. IMT has been synonymously referred to as in-
flammatory pseudotumor, pseudosarcomatous myofibro-
blastic lesion, pseudosarcomatous fibromyxoid lesion or 
plasma cell granuloma. These words are synonymous and 
have been in common use, all sharing a key pathologic dif-
ferentiation; a dominant spindle cell proliferation with a 
variable inflammatory component. These spindle cells are 
in fact myofibroblasts, thus, the preferred term for refer-
ence should be IMT reflective of the pathologic characters 
despite the persistence of others [5].Eun Young Kim, et al.
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Fig. 2. Trans-axial view (A) and coronal view (B) show a 4.0 cm sized homogeneous enhancing intra-luminal mass (arrow) in descending 
colon.
Fig. 1. Endoscopic examination reveals a 4 cm sized irregularly 
margined mass with intact mucosa (margin) and shallow ulcer 
(central) in descending colon.
We report an uncommon case of 35-year-old man pre-
senting with complaints of anal bleeding and histopatho-
logically diagnosed with descending colonic IMT after 
operation. 
CASE REPORT
A 35-year-old man presented with anal bleeding after 
defecation for 2 weeks. It is not associated with the symp-
toms of abdominal pain, fever or weight loss. He had taken 
oil mixed with a trace of benzopyrene for 3 years because 
of his job of checking oil type in the edible oil plant. He had 
been treated for variant angina and underwent hernior-
rhaphy for inguinal hernia 12 years ago. Vital signs, phys-
ical examination, and peripheral blood analysis 
(hemoglobin 14.5 g/dL, hematocrit 43.2%) were in the nor-
mal range. Colonoscopy demonstrated a 4.0 cm 
sized-mass with shallow ulceration in the central area and 
irregular margin accompanied by intact mucosa (Fig. 1). 
Microscopic examination of biopsy specimens showed 
chronic inflammation. Computer tomography showed a 
well-demarcated and homogenous solitary mass in the de-
scending colon. On contrast enhanced view, the mass had 
enhanced homogeneously in delayed phase (Fig. 2A, B). 
Colonoscopy was performed for clipping and tattooing 
and the patient underwent a laparoscopic anterior 
resection. On laparoscopy, a considerable amount of as-
cites (about 30 mL) and enlarged mesocolic lymph nodes 
were shown. The lymph nodes were resected and frozen 
biopsy concluded all lymph nodes were negative for 
malignancy. Because the main tumor was found to arise 
from descending colon, left colic branch of inferior mesen-
teric artery (IMA) and inferior mesenteric vein were li-
gated while IMA was preserved, then laparoscopic ante-
rior resection was performed. After the main mass was re-
sected, hand-sewing colocolic anastomosis was IMT in colon
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Fig. 3. Gross examination reveals a 3.9 × 3.8 cm sized, fungating, white to yellow colored and hard mass in descending colon. Mass involves 
muscularis propria.
Fig. 5. Tumor cells stain strongly for vimentin and variably with myoid markers including smooth muscle actin, muscle-specific actin and 
desmin (A, vimentin, ×200; B, actin, ×200).
Fig. 4. Tumor is composed of cytologically bland spinle cells arranged in hyaline stroma with scattered inflammatory cells. Inflammatory cells 
are composed of lymphocytes, histiocytes and plasma cells (A, H&E, ×40; B, H&E, ×400).
performed. The 3.9 × 3.8 cm sized mass grossly presented 
a fungating surface, white to yellow color and invaded 
muscularis propria (Fig. 3). Consistency of the mass was 
harder than adenocarcinoma. The histopathologic exami-
nation of the specimens showed the tumor was composed 
of a proliferation of spindle-shaped cells arranged in hya-Eun Young Kim, et al.
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line material with chronic inflammatory cells, composed 
mainly of plasma cells and lymphocytes, not neutrophils. 
The specimens did not have celluar atypia or hyper-
chromatism in the cells (Fig. 4A, B). Immunohistochem-
ical staining suggested that fibroblastic tissue was of my-
ofibroblastic nature. Immunohistochemically, tumor cells 
were positive for smooth muscle actin, and vimentin, and 
negative for desmin, CD117 (c-kit), anaplastic lymphoma 
kinase (ALK)-1 (Fig. 5A, B). These findings were compat-
ible with an IMT.
The patient’s postoperative course was uneventful, and 
he was discharged on the 7th postoperative day. He has 
been free of complication after 1 month of follow-up.
DISCUSSION
IMT was originally described in the lungs in 1937, and 
since then has been reported at various sites such as mes-
entery, stomach, small intestine, large intestine, liver, me-
diastinum, retroperitoneum and bladder [1,2,6]. The most 
common site of IMTs is the lung and the most common 
sites of extrapulmonary inflammatory myofibroblastic tu-
mor are the mesentery and omentum [1,2,6,7]. Among ex-
trapulmonary IMT, 43% arose in the mesentery and omen-
tum [7]. Although it occurs primarily in children and 
young adults (mean age, approximately 10 years), in more 
recent years a broad age range has been documented [1]. 
There is no difference in incidence between females and 
males, though each report has a difference in mean age 
and gender ratio [2,5].
The etiology of IMT is still unknown. But some people 
think that development of IMT occurs after trauma, sur-
gery or infection such as Epstein-Barr virus and human 
herpes virus related with reactive cytokine production 
[6,7]. A recent study reports that these lesions may possess 
chromosomal aberrations with resultant monoclonality 
and may frequently demonstrate locally aggressive 
behavior. As such, this entity should better be considered 
a neoplastic process. A chromosomal rearrangement in-
volving 2p23, the site of the ALK gene, is present in a subset 
of these tumors [5]. These findings have recently shown 
that chromosomal abnormalities may be suggestive of clo-
nal origin, not merely a reactive process. IMT should be 
considered as a true neoplasm [5].
Several cases with IMT in the colon have been con-
firmed in other countries. A total of 5 cases have been re-
ported during the last ten-year period. The patients with 
IMT presented with anemia, intussusception, fecal occult 
blood positive, abdominal pain, chest pain, fever or 
weight loss. Except 1 case, all cases reported were in males. 
From 32-month-old to 79-year-old, a broad age range of 
IMT has been documented. The most common site of 
documented IMT in the colon was the right colon 
(ascending colon, 2 cases; cecum, 2 cases). IMT in the trans-
verse colon (1 case) was also reported [1,3,4]. A retro-
spective review of the medical records was conducted at 
two major academic institutions over a 15-year period by 
Kovach et al. [5]. Review of the records from two in-
stitutions yielded 44 cases of pathologically confirmed 
IMT. Among these cases, only 3 cases occurred in colon [5].
Differential diagnosis of IMT includes malignancy and 
submucosal tumor from endoscopic findings. In this case, 
on endoscopic examination, we need to distinguish IMT 
from lymphoma and submucosal tumor composed of in-
tact mucosal margin. Radiologically differential diagnosis 
of abdominal IMT includes solitary fibrous tumor and fi-
bromatoses (desmoid tumor). 
Inflammatory fibroid polyp, fibromatoses (desmoid tu-
mor), gastrointestinal stromal tumors (GIST), leiomyoma, 
leiomyosarcoma, and schwannoma have similar patho-
logical findings with IMT. Inflammatory fibroid polyp is 
typically submucosal and consists of a mixture of small 
granulation tissue-like vessels, spindle cells, and in-
flammatory cells (particulary eosinophils). Fibromatoses 
are composed of bland spindled or stellate cells, arranged 
in parallel with evenly spaced blood vessels and a collage-
nous background. Fibromatoses often have mitotic activ-
ity, but cytologic pleomorphism is generally not seen. 
GIST stains for CD34 and CD117 (c-kit). Leiomyoma and 
leiomyosarcoma stain positively for desmin and actin and 
negatively for CD117 and CD34. Schwannoma stains 
strongly for S-100 (nuclear and cytoplasmic) and is CD117 
negative [1,6,8]. Immunohistochemically, strong diffuse 
cytoplasmic reactivity for vimentin is typical for virtually 
all IMT. Reactivity for smooth muscle actin and muscle IMT in colon
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specific actin varies from a focal to a diffuse pattern in the 
spindle cell cytoplasm, and desmin is identified in many 
cases [7]. Immunohistochemical cytoplasmic positivity for 
ALK using a variety of monoclonal antibodies is shown in 
approximately 50% of IMTs. However, ALK positivity is 
not specific for IMT [7]. Because IMT is rare and sometimes 
similar with malignancy, even after various examinations, 
it is important to distinguish IMT from other colonic 
tumors. IMT cannot be diagnosed by preoperation biopsy. 
Also, the tumor occasionally undergoes malignant trans-
formation if not surgically excised, therefore surgical re-
section is the treatment of choice. We cannot exclude ma-
lignancy completely preoperatively, so it is hard to de-
termine surgical resection margin. We have to understand 
IMT accurately and be careful to prevent over diagnosis 
and unnecessary operation and treatment.
Chemotherapy, radiation treatment, nonsteroidal an-
ti-inflammatory drug (NSAID), steroid and cyclosporin- A 
have been used as treatment modalities, but surgical re-
section is considered as treatment of choice [5,6]. It rarely 
presents recurrence, metastasis or malignant transforma-
tion, and is classified as intermediate neoplasm in the 
World Health Organization histological typing, but it may 
recur locally or manifest systemic symptoms. It is for this 
reason that regular follow-up is necessary even though 
surgical resection was done [2,7].
Several studies have reported that ALK positive tumors 
have a less aggressive clinical course, although no clear re-
lationship exists between ALK expression and prognosis 
in IMT [2,7,9,10]. In addition, there have been some studies 
that reported a correlation between p53 expression and 
prognosis [2,10]. The role of p53 reactivity in predicting 
the behavior of IMTs is uncertain [2,10]. The etiology of 
IMT is still unknown, neither reactive process nor neo-
plasm. And it is unclear about natural course of IMT, un-
less surgical resection is done.
Most IMTs behave in a benign manner after surgical re-
section, but it presents recurrence, metastasis or malignant 
transformation in some cases. It is unclear what kind of 
factor is associated with prognosis. Also, it is unclear what 
the best way of treatment of recurrence or metastasis is 
during long-term follow-up. We have to follow-up pa-
tients diagnosed IMT even if they have undergone surgi-
cal resection.
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